# Page 1
Haffkine Biopharmaceuticals Limited (MIRIA), Mumbai, has received approval for funding the project to manufacture Covaxin vaccine in collaboration with the Central and State Governments.
The Government of Maharashtra
Department of Medical Education and Drugs
Government Resolution No: HBP 2021/ Q. No. 53/21/ Drugs-1
Gokuldas Tejpal Hospital Complex Building,
Ministry of New and Renewable Energy, Mumbai- 40001
Date is April 29, 2021.
Read: 1. Minutes of the review meeting held by the Chief Minister on 09.02.2021.
2) Ma. Chief Minister's meeting held on 20th March, 2021 at Haffkine Jeeva Pharmaceuticals Corporation (HAFFDCO), Mumbai.
3) The Managing Director, Haffkine Biopharmaceuticals Manufacturing Corporation (MIRIA), Mumbai vide letter No.
Haffkine/ 2021/98, dated 12th April 2021.
4) Dr. R.A. Mashelkar's committee submitted to the government. Report dated 16.04.2018.
Secretary, Department of Biotechnology, Ministry of Science and Technology, Government of India
Do not. SBT/ 46/2021, dated 15.04.2021.
6) Biotechnology Industry Research Assistance Council (BIRAC), Ministry of Science and Technology, Government of India. dated 27.04.2021.
Preamble: Haffkine Jeevi dated 01.09.1975 by splitting the then Haffkine Institute
Pharmaceuticals Manufacturing Corporation (MRITA), Mumbai is a legally incorporated company under the provisions of the Companies Act, 1956 as a registered business of the Government of Maharashtra. The company is a leader in the production of life-saving vaccines at very affordable prices. Haffkine Corporation
Breathe is dedicated to the service of humanity and according to this, the corporation's life-saving vaccines, medicines, antidotes, etc. are distributed to government health institutions as well as the central government.
A universal vaccination campaign is underway. Global Polio Vaccine Production
# Page 2
Government Resolution No: HBP 2021/ Q. No. 53/21/ Drugs-1
Haffkine is the only public sector corporation to be accredited by the Health Organization, Geneva, Switzerland.
The COVID-19 pandemic has been raging in India, including Maharashtra, since March 2020. To prevent this infection, it is necessary to make the vaccine available to the general public in sufficient quantities. Anushnge, Ma. A review meeting of Haffkine Corporation and Haffkine Institute was held on 9.2.2021 under the chairmanship of the Chief Minister. In this meeting, Haffkine Corporation received various vaccines.
Having prior experience in research and manufacturing, Haffkine Corporation has been directed to prioritize the production of vaccines against various diseases. in this regard on 20.3.2021. The Chief Minister visited both the institutions. During the meeting, he directed to take necessary measures to immediately start the production of the Covid-19 vaccine, which is necessary to increase the speed of vaccination. The Chief Minister has given the Haffkine to the corporation.
In order to ensure adequate availability of COVID-19 vaccines to the people of the country, the Biotechnology Industry Research Assistance Council (BIRAC), under the Department of Biotechnology, Ministry of Science and Technology, Government of India, had invited expression of interest (EoI) in the month of January, 2021 to promote domestic production and availability of COVID-19 vaccines in adequate quantity. Accordingly, the Haffkine Corporation had submitted a proposal to the Central Government in this regard. In this regard, the Scientific and Advisory Group, the Apex Committee and the Budgetary Committee of the said Council of the Central Government have discussed this proposal from time to time through television (VC) in the month of April, 2021 of the Haffkine Corporation and accordingly, under the letter dated 15.04.2021, Bharat Biotech Ltd. The central government will support Haffkine Corporation's project to produce Covaxin vaccine by transferring the production technology from this company. Further, vide letter dated 27.04.2021, Haffkine Corporation has been sanctioned financial assistance of Rs.65 crore for implementation of the said project.
Page 2 of 9
# Page 3
Government Resolution No: HBP 2021/ Q. No. 53/21/ Drugs-1
Accordingly, on 16.03.2021, the Managing Director, Haffkine Biopharma Limited. Executive Director, Bharat Biotech. Talks with Hyderabad
Bharat Biotech Ltd. , Hyderabad has agreed to provide the technology required for the production of Covaxin vaccine to Haffkine Corporation vide their letter dated 19.03.2021. Once Haffkine acquires the technology, Haffkine Biopharmaceuticals will be able to start manufacturing Covaxin.
5. In pursuance of this, Haffkine Corporation at its premises at Parel, Mumbai, may. Bharat Biotech is developing Covaxin, India's indigenous Covid-19 vaccine. A proposal of Rs 154 crore has been submitted to the government for approval. The proposal of the Haffkine Corporation. The proposal was placed for consideration in the meeting of the Cabinet held on 28.4.2021. In this meeting, In accordance with the decision taken by the Cabinet, the approval of the Haffkine Corporation for the project and the proposal to finance it was under the consideration of the Government.
Government's decision:
Haffkine Biopharmaceuticals Limited As per the proposal submitted to the Government vide letter dated 12.04.2021, the Corporation has been allotted land at Parel, Mumbai with financial assistance from Central and State Government and Rs. Bharat Biotech International Limited (BBIL), Hyderabad, has received approval for manufacturing Covaxin, India's indigenous Covid-19 vaccine.
2. The cost of the project is Rs.154 crore. The Central Government has allotted Rs. 65 crore has been sanctioned out of which Rs. 59.8335 crore has been sanctioned as subsidy for capital expenditure (non-recurring) and Rs. 5.1665 crore as subsidy for recurring expenditure. The project cost is Rs 154 crore.
Page 9 of 3
# Page 4
Government Resolution No: HBP 2021/ Q. No. 53/21/ Drugs-1
Remaining Capital (Non-Convertible) Expenditure amounting to Rs. 94.1665 crore
Haffkine Corporation is being sanctioned as seed capital.
Approval is being given to withdraw the said sanctioned amount of Rs. 94.1665 crore from the State Contingency Fund for immediate commencement of construction of the project.
4. Approval is being given to send a letter to the Central Government regarding the full financial assistance of the State Government to the project.
5. Haffkine Jeeva Drug Corporation Limited to give written assurance in the project completion report regarding supply of manufactured vaccines to the Central Government and its approved agencies as per the price negotiated by the Central Government. Mumbai is approved.
6. Haffkine Corporation is being approved to contractually pay the manpower required for the project and to meet the recurring cost of the project from the production of the Corporation.
Since the project is to be constructed on a" turn key" basis and to be commissioned in a time bound manner, approval is being given to the company setting up the project through Haffkine Corporation to pay 50% of the advance amount in the initial phase of the project and the remaining 50% to be spent as per the requirement of the project.
8. Technology transfer of COVID-19 vaccine production for the project. Haffkine Corporation has been granted approval to enter into a confidentiality agreement and a memorandum of understanding (MoU) covering legal and commercial aspects with Bharat Biotech Ltd.
Further, while finalizing the provisions regarding Technology Transfer and Business Terms under the MoU, it is being approved to take the opinion of the Department of Law and Justice as well as the Department of Finance and Planning as required.
Page 9 of 4
# Page 5
Government Resolution No: HBP 2021/ Q. No. 53/21/ Drugs-1
9. Haffkine Corporation is being authorized to enter into all necessary agreements for vaccine production with other COVID-19 vaccine manufacturing companies, as required, subject to the conditions in (8) above.
10. Haffkine Corporation is being given approval to use the production facility of the project for manufacturing other vaccines after the requirement of the vaccine against COVID-19 is over.
11. The said Government Decision, with the concurrence of the Planning and Finance Departments respectively, vide their Informal Reference No. 119/1475, dated 27.04.2021 and No. 27/21/ SA, dated 27.04.2021
It is issued in accordance with the approval received.
# Page 6
# Page 7
# Page 8
# Page 9